#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebral amyloid angiopathy Anal cancer Philadelphia positive acute lymphocytic leukaemia Pulmonary sarcoidosis Osteogenesis imperfecta Candida infection Glomerulonephritis chronic Cholestatic pruritus Acute myeloid leukaemia refractory Atypical haemolytic uraemic syndrome Craniopharyngioma Amyotrophic lateral sclerosis gene carrier Prophylaxis against transplant rejection Hypoxic-ischaemic encephalopathy Idiopathic inflammatory myopathy More trials…

    Learn about Rare Diseases

    Alternating hemiplegia of childhood – Basic Information Mucopolysaccharidosis I – Diagnostics Hereditary motor and sensory neuropathy – Trials in Disease Short-bowel syndrome – Basic Information Mast cell activation syndrome – Trials in Disease Shprintzen-Goldberg syndrome – Diagnostics Arterial tortuosity syndrome – Diagnostics Myelodysplastic syndrome Leiomyosarcoma metastatic Hereditary angioedema with C1 esterase inhibitor deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fosfomycin Trometamol Propranolol Alteplase Hydroxypropyl Cellulose Lf Febuxostat Hemihydrate CITRIC ACID ANHYDROUS Fluoroethyltyrosine F-18 Romidepsin Nvl-655 Lasofoxifene OLVEREMBATINIB Ttx-030 Travoprost Brepocitinib Tosilate Tadalafil GSKVX000000034798 H2-Receptor Antagonist Oms906 Aficamten Resiniferatoxin More therapies…

    Learn about Your Condition

    Type 2 diabetes mellitus Hypertension Ejection fraction normal Reperfusion injury Breast conserving surgery Metastatic neoplasm Cystic fibrosis lung Medication overuse headache Hepatic cirrhosis Body mass index increased Round cell liposarcoma Mantle cell lymphoma stage IV Psychological trauma Back pain Albuminuria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Graalum

  • Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Benzathine Benzylpenicillin
    • BENZYLPENICILLIN POTASSIUM
    • BENZYLPENICILLIN PROCAINE
    Norway

  • Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger’s Disease) to Reduce Protein in Urine

    Recruiting

    3 1
    Austria Czechia France Germany Hungary Italy +6

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Iron deficiency
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6

  • Study on Clopidogrel and Dalteparin Sodium for Preventing Blood Clots in Pancreatic Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Clopidogrel
    • Dalteparin Sodium
    Norway

  • Study on Reducing Chronic Migraine Days with CGRP Antibodies and Botulinum Toxin A in Adults Aged 18-70

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Erenumab
    • Fremanezumab
    Norway
Previous Page
1 2 3 4 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Prednisone Tenecteplase Nivolumab Apixaban Asundexian Dexamethasone Pembrolizumab Cisplatin Hydrocortisone Polatuzumab Vedotin Amoxicillin Trihydrate Rbd4059 Povetacicept Benzathine Benzylpenicillin Oxygen Midazolam Hydrochloride Eltrombopag Riluzole Abiraterone Acetate BENZYLPENICILLIN POTASSIUM Hyoscine Butylbromide Ketamine Entecavir Rituximab Botulinum Toxin Type A Selatogrel Enzalutamide BENZYLPENICILLIN PROCAINE Sodium Hydrogen Carbonate Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute myocardial infarction Alcohol use disorder Amyotrophic lateral sclerosis Aortic valve stenosis Arteriosclerosis Atrial fibrillation Bladder cancer Cancer pain Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic obstructive pulmonary disease Cold type haemolytic anaemia Deafness neurosensory Depression Diffuse large B-cell lymphoma refractory Hormone-refractory prostate cancer Hypertension IgA nephropathy Immune thrombocytopenia Iron deficiency Ischaemic stroke Labour induction Lung disorder Major depression Malignant melanoma Metabolic dysfunction-associated steatohepatitis Metastatic neoplasm Migraine Monkeypox Non-alcoholic steatohepatitis Non-small cell lung cancer Non-small cell lung cancer metastatic Pancreatic carcinoma Plasma cell myeloma Pneumonia Primary adrenal insufficiency Renal cell carcinoma Retinal artery occlusion Sepsis Substance use disorder Thrombosis prophylaxis Transient ischaemic attack Transitional cell carcinoma metastatic Type 2 diabetes mellitus Type IIa hyperlipidaemia Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!